Company Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific.
The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products.
Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell.
The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis.
It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014.
10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.
| Country | United States |
| Founded | 2012 |
| IPO Date | Sep 12, 2019 |
| Industry | Health Information Services |
| Sector | Healthcare |
| Employees | 1,259 |
| CEO | Serge Saxonov |
Contact Details
Address: 6230 Stoneridge Mall Road Pleasanton, California 94588-3260 United States | |
| Phone | 925 401 7300 |
| Website | 10xgenomics.com |
Stock Details
| Ticker Symbol | TXG |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Share Class | Class A Shares |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $39.00 |
| CIK Code | 0001770787 |
| CUSIP Number | 88025U109 |
| ISIN Number | US88025U1097 |
| Employer ID | 45-5614458 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Serge Saxonov | Chief Executive Officer |
| Adam Taich | Chief Financial Officer |
| Jim Goodrich | Chief Operating Officer |
| Cassie Corneau | Head of Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 13, 2025 | 8-K | Current Report |
| Nov 22, 2024 | 144 | Filing |
| Nov 22, 2024 | 144 | Filing |
| Nov 8, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Nov 5, 2024 | SC 13G | Statement of acquisition of beneficial ownership by individuals |
| Oct 29, 2024 | 10-Q | Quarterly Report |
| Oct 29, 2024 | 8-K | Current Report |
| Oct 9, 2024 | 8-K | Current Report |
| Oct 4, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| Aug 22, 2024 | 144 | Filing |